MICHAEL FRONIEWSKI: Open Payments
NPI 1093287161 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,127 in 123 payments from 19 companies in 2025. Trend: 2023 $4,290 · 2024 $3,519 · 2025 $3,127
Food & beverage: $3,058Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $364 |
| Arcutis Biotherapeutics, Inc. | 10 | $337 |
| GENZYME CORPORATION | 7 | $311 |
| Regeneron Healthcare Solutions, Inc. | 7 | $263 |
| LEO Pharma Inc. | 11 | $257 |
| ABBVIE INC. | 16 | $238 |
| Novartis Pharmaceuticals Corporation | 5 | $226 |
| Lilly USA, LLC | 13 | $219 |
| E.R. Squibb & Sons, L.L.C. | 11 | $188 |
| Incyte Corporation | 7 | $172 |
Products named: DUPIXENT, TREMFYA, Zoryve, TALTZ, Sotyktu, OPZELURA, ANZUPGO, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
